Immune profiling
. | . | P1 . | P2 . | P3 . | P4 . | P5 . | P6 . |
---|---|---|---|---|---|---|---|
Naïve B cells, %∗ Normal range, 58%-86.7% | DFT baseline | 30.70 | 26.80 | 38.50 | 11.00 | 30.30 | 53.60 |
Latest time point | ↑, 90.20 | ↑, 81.70 | ↑, 50.80 | ↑, 75.00 | ↑, 84.50 | ↑, 81.40 | |
Switched memory B cells, %∗ Normal range, 3.3%-18.9% | DFT baseline | 45.60 | 46.60 | 45.10 | 31.60 | 60.50 | 32.00 |
Latest time point | ↓, 4.20 | ↓, 3.80 | ↓, 34.90 | ↓, 5.80 | ↓, 18.10 | ↓, 28.40 | |
Nonswitched memory B cells, %∗ Normal range, 4.6%-21.4% | DFT baseline | 4.90 | 38.60 | 1.10 | 58.70 | 17.80 | 0.40 |
Latest time point | ↑, 7.30 | ↑ 47.80 | ↑, 3.00 | ↓, 44.80 | ↑, 18.20 | ↑, 0.60 | |
Transitional B cells, % Normal range, 1.5%-19.1% | DFT baseline | 60.50 | 19.20 | 46.60 | 27.00 | 44.10 | 31.60 |
Latest time point | ↓, 0.98 | ↓, 6.45 | ↓, 2.53 | ↓, 0.00 | ↓, 3.30 | ↓, 11.25 | |
Senescent CD4+ T cells, % Normal range, 0.18%-5.99% | DFT baseline | 21.10 | 13.80 | 15.50 | 34.00 | 7.30 | 0.90 |
Latest time point | ↓, 5.08 | ↓, 5.10 | ↓, 15.09 | ↓, 5.39 | ↓, 0.60 | ↓, 0.10 | |
Senescent CD8+ T cells, % Normal range, 1.83%-33.4% | DFT baseline | 33.20 | 21.60 | 24.60 | 43.00 | 19.70 | 14.60 |
Latest time point | ↓, 24.44 | ↑, 24.10 | ↑, 35.77 | ↓, 31.46 | ↓, 4.80 | ↓, 3.10 | |
CD4+ T cells, % Normal range, 29.3%-52.9% | DFT baseline | 34.00 | 49.40 | 33.10 | 43.30 | 42.10 | 28.60 |
Latest time point | ↑, 39.90 | ↓, 47.38 | ↑, 47.85 | ↑, 59.27 | ↓, 39.0 | ↑, 46.40 | |
CD8+ T cells, % Normal range, 13.5%-23.5% | DFT baseline | 65.30 | 49.50 | 66.40 | 55.60 | 56.30 | 70.80 |
Latest time point | ↓, 51.56 | ↑, 50.50 | ↓, 48.54 | ↓, 34.03 | ↓, 31.00 | ↓, 54.7 | |
Naïve CD4+ T cells, % Normal range, 49.3%-72% | DFT Baseline | 11.70 | 19.20 | 6.90 | 6.40 | 4.90 | 12.90 |
Latest time point | ↑, 28.49 | ↑, 28.02 | ↑, 22.64 | ↑, 18.06 | ↑, 8.60 | ↑, 15.20 | |
Naïve CD8+ T cells, % Normal range, 48.6%-87.5% | DFT baseline | 18.90 | 37.10 | 15.40 | 23.60 | 23.00 | 17.00 |
Latest time point | ↑, 29.90 | ↓, 26.30 | ↑, 32.90 | ↑, 25.82 | ↓, 21.40 | ↑, 41.30 | |
CD4+ TEM cells, % Normal range, 2.1%-7.4% | DFT baseline | 24.50 | 21.50 | 31.30 | 27.40 | 27.00 | 25.40 |
Latest time point | ↓, 18.69 | ↑, 24.19 | ↓, 28.16 | ↓, 25.34 | ↑, 28.60 | ↓, 8.90 | |
CD8+ TEM cells, % Normal range, 0.2%-6.9% | DFT baseline | 41.30 | 22.40 | 27.50 | 36.60 | 25.90 | 29.40 |
Latest time point | ↓, 29.49 | ↑, 31.47 | ↓, 25.32 | ↑, 39.91 | ↑, 33.30 | ↓, 14.90 | |
CD4+ TEMRA cells, % Normal range, 0.1%-8.5% | DFT baseline | 0.10 | 0.10 | 0.10 | 0.00 | 27.00 | 0.10 |
Latest time point | ↓, 0.00 | ↑, 1.27 | ↑, 0.58 | ↑, 0.27 | ↓, 0.10 | ↓, 0.00 | |
CD8+ TEMRA cells, % Normal rang, 0.8%-14% | DFT Baseline | 8.00 | 13.20 | 3.10 | 7.80 | 25.90 | 22.90 |
Latest time point | ↓, 5.06 | ↑, 33.47 | ↑, 7.44 | ↑, 13.62 | ↓, 13.70 | ↓, 11.50 | |
CD4+ TCM cells, % Normal range, 24.3%-44.4% | DFT baseline | 64.30 | 59.30 | 61.80 | 66.20 | 68.10 | 61.70 |
Latest time point | ↓, 52.63 | ↓, 36.52 | ↓, 48.77 | ↓, 56.06 | ↓, 62.80 | ↑, 75.90 | |
CD8+ TCM cells, % Normal range, 9.8%-37.6% | DFT baseline | 31.90 | 27.40 | 54.10 | 32.10 | 39.80 | 30.80 |
Latest time point | ↑, 35.53 | ↓, 8.56 | ↓, 34.33 | ↓, 13.62 | ↓, 31.80 | ↑, 43.80 | |
IgM, mg/dL Normal range, 20-230 mg/dL | DFT baseline | 220 | 335 | 282 | 752 | 686 | 190 |
Latest time point | ↓, 18 | ↓, 66 | ↓,68 | ↓, 264 | ↓, 166 | ↓, 91 | |
IgA, mg/dL Normal range, 87-386 mg/dL | DFT baseline | 125 | 81 | 137 | 50 | 253 | 149 |
Latest time point | ↑, 157 | 81 | ↑, 188 | ↑, 102 | ↑, 346 | ↑, 153 | |
IgE, μg/L Normal range, 6-495 μg/L | DFT baseline | 7 | 8 | 7 | 7 | 194 | 6063 |
Latest time point | ↑, 25 | ↑, 25 | ↑, 25 | ↓, 1 | ↑, 221 | ↓, 630 | |
IgG, mg/dL Normal range, 586-1613 mg/dL | DFT baseline | 1444 (IRT) | 2036 (IRT) | 1644 (IRT) | 711 | 773 (IRT) | 1670 (IRT) |
Latest time point | ↓, 599 | ↓, 1631 (IRT) | ↓, 1412 (IRT) | ↓, 603 | ↑, 782 (IRT) | ↓, 890 | |
IgG1, mg/dL Normal range, 248-846 mg/dL | DFT baseline | 910 | 1150 | 1130 | 510 | 620 | 1250 |
Latest time point | ↓, 770 | ↓, 1030 | ↑, 1210 | ↑, 540 | ↑, 631‡ | ↓, 574‡ | |
IgG2, mg/dL Normal range, 130-555 mg/dL | DFT baseline | 336 | 710 | 280 | 60 | 340 | 480 |
Latest time point | ↓, 300 | ↓, 640 | ↓, 170 | ↓, 20 | ↓, 293† | ↓, 118† | |
IgG3, mg/dL‡ Normal range, 15-109 mg/dL | DFT baseline | 44 | 60 | 100 | 80 | 10 | 90 |
Latest time point | ↓, 20 | ↓, 30 | ↓, 60 | ↓, 60 | 10† | ↓, 68† | |
IgG4, mg/dL‡ Normal range, 2-104 mg/dL | DFT baseline | 67 | 50 | 10 | 10 | 10 | 30 |
Latest time point | ↓, 10 | ↓, 40 | ↓, 0 | ↓, 0 | ↑, 24† | ↓, 13† |
. | . | P1 . | P2 . | P3 . | P4 . | P5 . | P6 . |
---|---|---|---|---|---|---|---|
Naïve B cells, %∗ Normal range, 58%-86.7% | DFT baseline | 30.70 | 26.80 | 38.50 | 11.00 | 30.30 | 53.60 |
Latest time point | ↑, 90.20 | ↑, 81.70 | ↑, 50.80 | ↑, 75.00 | ↑, 84.50 | ↑, 81.40 | |
Switched memory B cells, %∗ Normal range, 3.3%-18.9% | DFT baseline | 45.60 | 46.60 | 45.10 | 31.60 | 60.50 | 32.00 |
Latest time point | ↓, 4.20 | ↓, 3.80 | ↓, 34.90 | ↓, 5.80 | ↓, 18.10 | ↓, 28.40 | |
Nonswitched memory B cells, %∗ Normal range, 4.6%-21.4% | DFT baseline | 4.90 | 38.60 | 1.10 | 58.70 | 17.80 | 0.40 |
Latest time point | ↑, 7.30 | ↑ 47.80 | ↑, 3.00 | ↓, 44.80 | ↑, 18.20 | ↑, 0.60 | |
Transitional B cells, % Normal range, 1.5%-19.1% | DFT baseline | 60.50 | 19.20 | 46.60 | 27.00 | 44.10 | 31.60 |
Latest time point | ↓, 0.98 | ↓, 6.45 | ↓, 2.53 | ↓, 0.00 | ↓, 3.30 | ↓, 11.25 | |
Senescent CD4+ T cells, % Normal range, 0.18%-5.99% | DFT baseline | 21.10 | 13.80 | 15.50 | 34.00 | 7.30 | 0.90 |
Latest time point | ↓, 5.08 | ↓, 5.10 | ↓, 15.09 | ↓, 5.39 | ↓, 0.60 | ↓, 0.10 | |
Senescent CD8+ T cells, % Normal range, 1.83%-33.4% | DFT baseline | 33.20 | 21.60 | 24.60 | 43.00 | 19.70 | 14.60 |
Latest time point | ↓, 24.44 | ↑, 24.10 | ↑, 35.77 | ↓, 31.46 | ↓, 4.80 | ↓, 3.10 | |
CD4+ T cells, % Normal range, 29.3%-52.9% | DFT baseline | 34.00 | 49.40 | 33.10 | 43.30 | 42.10 | 28.60 |
Latest time point | ↑, 39.90 | ↓, 47.38 | ↑, 47.85 | ↑, 59.27 | ↓, 39.0 | ↑, 46.40 | |
CD8+ T cells, % Normal range, 13.5%-23.5% | DFT baseline | 65.30 | 49.50 | 66.40 | 55.60 | 56.30 | 70.80 |
Latest time point | ↓, 51.56 | ↑, 50.50 | ↓, 48.54 | ↓, 34.03 | ↓, 31.00 | ↓, 54.7 | |
Naïve CD4+ T cells, % Normal range, 49.3%-72% | DFT Baseline | 11.70 | 19.20 | 6.90 | 6.40 | 4.90 | 12.90 |
Latest time point | ↑, 28.49 | ↑, 28.02 | ↑, 22.64 | ↑, 18.06 | ↑, 8.60 | ↑, 15.20 | |
Naïve CD8+ T cells, % Normal range, 48.6%-87.5% | DFT baseline | 18.90 | 37.10 | 15.40 | 23.60 | 23.00 | 17.00 |
Latest time point | ↑, 29.90 | ↓, 26.30 | ↑, 32.90 | ↑, 25.82 | ↓, 21.40 | ↑, 41.30 | |
CD4+ TEM cells, % Normal range, 2.1%-7.4% | DFT baseline | 24.50 | 21.50 | 31.30 | 27.40 | 27.00 | 25.40 |
Latest time point | ↓, 18.69 | ↑, 24.19 | ↓, 28.16 | ↓, 25.34 | ↑, 28.60 | ↓, 8.90 | |
CD8+ TEM cells, % Normal range, 0.2%-6.9% | DFT baseline | 41.30 | 22.40 | 27.50 | 36.60 | 25.90 | 29.40 |
Latest time point | ↓, 29.49 | ↑, 31.47 | ↓, 25.32 | ↑, 39.91 | ↑, 33.30 | ↓, 14.90 | |
CD4+ TEMRA cells, % Normal range, 0.1%-8.5% | DFT baseline | 0.10 | 0.10 | 0.10 | 0.00 | 27.00 | 0.10 |
Latest time point | ↓, 0.00 | ↑, 1.27 | ↑, 0.58 | ↑, 0.27 | ↓, 0.10 | ↓, 0.00 | |
CD8+ TEMRA cells, % Normal rang, 0.8%-14% | DFT Baseline | 8.00 | 13.20 | 3.10 | 7.80 | 25.90 | 22.90 |
Latest time point | ↓, 5.06 | ↑, 33.47 | ↑, 7.44 | ↑, 13.62 | ↓, 13.70 | ↓, 11.50 | |
CD4+ TCM cells, % Normal range, 24.3%-44.4% | DFT baseline | 64.30 | 59.30 | 61.80 | 66.20 | 68.10 | 61.70 |
Latest time point | ↓, 52.63 | ↓, 36.52 | ↓, 48.77 | ↓, 56.06 | ↓, 62.80 | ↑, 75.90 | |
CD8+ TCM cells, % Normal range, 9.8%-37.6% | DFT baseline | 31.90 | 27.40 | 54.10 | 32.10 | 39.80 | 30.80 |
Latest time point | ↑, 35.53 | ↓, 8.56 | ↓, 34.33 | ↓, 13.62 | ↓, 31.80 | ↑, 43.80 | |
IgM, mg/dL Normal range, 20-230 mg/dL | DFT baseline | 220 | 335 | 282 | 752 | 686 | 190 |
Latest time point | ↓, 18 | ↓, 66 | ↓,68 | ↓, 264 | ↓, 166 | ↓, 91 | |
IgA, mg/dL Normal range, 87-386 mg/dL | DFT baseline | 125 | 81 | 137 | 50 | 253 | 149 |
Latest time point | ↑, 157 | 81 | ↑, 188 | ↑, 102 | ↑, 346 | ↑, 153 | |
IgE, μg/L Normal range, 6-495 μg/L | DFT baseline | 7 | 8 | 7 | 7 | 194 | 6063 |
Latest time point | ↑, 25 | ↑, 25 | ↑, 25 | ↓, 1 | ↑, 221 | ↓, 630 | |
IgG, mg/dL Normal range, 586-1613 mg/dL | DFT baseline | 1444 (IRT) | 2036 (IRT) | 1644 (IRT) | 711 | 773 (IRT) | 1670 (IRT) |
Latest time point | ↓, 599 | ↓, 1631 (IRT) | ↓, 1412 (IRT) | ↓, 603 | ↑, 782 (IRT) | ↓, 890 | |
IgG1, mg/dL Normal range, 248-846 mg/dL | DFT baseline | 910 | 1150 | 1130 | 510 | 620 | 1250 |
Latest time point | ↓, 770 | ↓, 1030 | ↑, 1210 | ↑, 540 | ↑, 631‡ | ↓, 574‡ | |
IgG2, mg/dL Normal range, 130-555 mg/dL | DFT baseline | 336 | 710 | 280 | 60 | 340 | 480 |
Latest time point | ↓, 300 | ↓, 640 | ↓, 170 | ↓, 20 | ↓, 293† | ↓, 118† | |
IgG3, mg/dL‡ Normal range, 15-109 mg/dL | DFT baseline | 44 | 60 | 100 | 80 | 10 | 90 |
Latest time point | ↓, 20 | ↓, 30 | ↓, 60 | ↓, 60 | 10† | ↓, 68† | |
IgG4, mg/dL‡ Normal range, 2-104 mg/dL | DFT baseline | 67 | 50 | 10 | 10 | 10 | 30 |
Latest time point | ↓, 10 | ↓, 40 | ↓, 0 | ↓, 0 | ↑, 24† | ↓, 13† |
Values for DFT baseline were collected from the DFT B- and T-cell immunophenotyping files. Values for latest time point were captured from both the OLE B- and T-cell immunophenotyping files and by trial investigators. Values outside the normal range are italicized. Normal laboratory values are from the literature.29-34,37-40
↓, below normal limits; ↑, above normal limits; TCM, central memory T cells; TEMRA, terminally differentiated effector memory CD4+ and CD8+ T cells.
Denotes immune subsets that were only collected up to year 1 of the extension study.
Data were collected past year 1.
For values that were reported <[value], the actual value was entered.